Dr. Reddy's Laboratories LimitedRDYNYSE
LOADING
|||
EBITDA Over Time
Above historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$96.67B
↑ 105% above average
Average (9y)
$47.09B
Historical baseline
Range
High:$96.67B
Low:$534.77M
CAGR
+10.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $96.67B | +9.3% |
| 2024 | $88.42B | +18.8% |
| 2023 | $74.43B | +65.1% |
| 2022 | $45.08B | +8329.7% |
| 2021 | $534.77M | -98.7% |
| 2020 | $41.78B | +17.6% |
| 2019 | $35.52B | +49.7% |
| 2018 | $23.73B | -3.3% |
| 2017 | $24.55B | -38.9% |
| 2016 | $40.17B | - |